Summit Therapeutics

Summit Therapeutics FCF per Share

The Free Cash Flow per Share of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -0.20 USD. In the previous year, Free Cash Flow per Share was -0.12 USD — a change of 59.54% (lower).

FCF per Share

-0.20USD

YoY

59.54%

Last updated:

Free Cash Flow per Share of Summit Therapeutics is 2024 -0.20 USD. Free Cash Flow per Share of Summit Therapeutics was 2023 -0.12 USD. It decreases by 59.54% lower compared to the previous year.

The Summit Therapeutics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
-1.71 USD
Jan 1, 2018
-2.05 USD
Jan 1, 2019
-0.64 USD
Jan 1, 2020
-0.70 USD
Jan 1, 2021
-0.79 USD
Jan 1, 2022
-0.22 USD
Jan 1, 2023
-0.12 USD
Jan 1, 2024
-0.20 USD
The Summit Therapeutics FCF per Share history
YEARFCF per ShareYoY
-0.20USD+59.54%
-0.12USD-43.15%
-0.22USD-72.38%
-0.79USD+13.22%
-0.70USD+8.61%
-0.64USD-68.60%
-2.05USD+20.05%
-1.71USD-970.95%
0.20USD-167.07%
-0.29USD+1.66%
-0.29USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Free Cash Flow per Share of Summit Therapeutics is -0.20 USD in 2024.

Free Cash Flow per Share of Summit Therapeutics changed from -0.12 USD to -0.20 USD, representing a 59.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Summit Therapeutics

All Key Metrics — Summit Therapeutics